OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutical Sciences is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer	228
Biophysical and permeability characterization of lyophilized (freeze-dried) human cadaver skin	198
Editorial Board	186
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases	158
CYP2E1 mediated advanced oxidation protein products exacerbate acetaminophen induced drug-derived liver injury in vitro and in vivo	137
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremia	126
Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice	126
Natural borneol serves as an adjuvant agent to promote the cellular uptake of piperlongumine for improving its antiglioma efficacy	112
The effect of formulation composition and flow conditions on the robustness of semisolid extrusion 3D printing: a case study on poorly water-soluble itraconazole for oral dosage form production	96
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation	77
Evaluating rat and canine microbiota models for predicting human colonic prodrug metabolism	69
Application of a forward design-based multi-attribute decision-making method in quality assessment in pharmaceutical tablet manufacturing	65
Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets	59
3D printed extended-release hydrochlorothiazide tablets	58
Evaluating the influence of the initial high molecular weight level on monoclonal antibody particle formation kinetics using a short-term chemical stress study	58
Surrogate-based LC–MS/MS quantification of endogenous creatinine in plasma, plasma-equivalent dried spots (qDPS), and volumetric absorptive microsampling (VAMS): an ICH M10-compliant bridging study	56
Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis	53
In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT–THP-1 Co-Culture Model	53
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways	53
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification	51
Development and optimization of Soluplus®/Pluronic-based polymeric micelles for bicalutamide delivery: characterization, lyophilization, stability, and cellular studies	49
Opportunities of topical drug products in a changing dermatological landscape	46
Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material	46
Exposure–response modeling of QTc interval and creatine kinase-MB in healthy people and treatment-naïve adults living with HIV-1 treated with ainuovirine monotherapy or combined with lamivudine and te	46
Intranasal propranolol hydrochloride-loaded PLGA-lipid hybrid nanoparticles for brain targeting: Optimization and biodistribution study by radiobiological evaluation	44

Nitrite testing in excipients – Industry best practices	44
In vitro identification of decreased function genetic variants of ABCB1	43
Impact of protein adsorption during biopharmaceutical manufacture & storage	41
Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma	41
FOSL1 mediates collagen synthesis and myofibroblast transformation in aortic fibroblasts under Ang II-induced aortic dissection conditions	40
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin–Farnesol) as a local drug delivery system	40
Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols	39
Microparticles and multi-unit systems for advanced drug delivery	38
Triplet Radio-Chemo-Immunotherapy Reprograms the PD-L1–CDK6 Axis to Remodel the Tumor Microenvironment and Overcome Immune Resistance in Head and Neck Cancer	38
Corrigendum to “iRGD-modified peptide–drug conjugate improves brain delivery and antitumor efficacy in glioblastoma” [European Journal of Pharmaceutical Sciences 224 (2026) 107599]	37
Virtual special issue of Nordic POP: Patient-oriented products	37
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach	37
Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: A population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite	37